CED
Showing 1 - 25 of 169
Aveir AR Coverage With Evidence Development (CED) Study
Not yet recruiting
- Cardiac Pacemaker
- +2 more
- Aveir AR Leadless Pacemaker
- Single-chamber atrial transvenous pacemaker
- (no location specified)
Oct 30, 2023
Medicare Anti-Aß mAb Coverage With Evidence Development Study
Recruiting
- Mild Alzheimer's Disease
- Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
- Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
-
Baltimore, MarylandCenters for Medicare and Medicaid Services
Sep 21, 2023
AVEIR DR Coverage With Evidence Development (CED) Study
Not yet recruiting
- Cardiac Pacemaker
- +2 more
- Aveir DR Leadless Pacemaker System
- Dual Chamber Transvenous Pacemaker
- (no location specified)
Jul 5, 2023
Celiac Disease, Food Intolerance Trial in Oslo (Wheat gluten 1000 mg, Barley gluten 1000 mg, Barley gluten 50 mg)
Recruiting
- Celiac Disease
- Food Intolerance
- Wheat gluten 1000 mg
- +3 more
-
Oslo, NorwayDept of Gastroenterology
Nov 28, 2023
Chronic Inflammatory Intestinal Diseases (CED) Trial in Aachen (intervention group)
Completed
- Chronic Inflammatory Intestinal Diseases (CED)
- intervention group
-
Aachen, NRW, GermanyClinic for Pediatrics and Youth Medicine, University Hospital of
Oct 25, 2022
Diffuse Intrinsic Pontine Glioma, Diffuse Pontine and Thalamic Gliomas, Diffuse Midline Glioma Trial in New York (Infusate with
Recruiting
- Diffuse Intrinsic Pontine Glioma
- +2 more
- Infusate with MTX110 and gadolinium
- Convection-Enhanced Delivery (CED)
-
New York, New YorkColumbia University Irving Medical Center
Mar 8, 2022
Mesial Temporal Lobe Epilepsy Trial in Columbus (AAV9-hSyn1-miGRIK2)
Not yet recruiting
- Mesial Temporal Lobe Epilepsy
- AAV9-hSyn1-miGRIK2
-
Columbus, OhioOhio State University
Sep 25, 2023
Longitudinal Coverage With Evidence Development Study on Micra
Active, not recruiting
- Bradycardia
-
Atlanta, GeorgiaEmory University
Aug 4, 2022
Diffuse Intrinsic Pontine Glioma Trial in San Francisco (Panobinostat Nanoparticle Formulation MTX110, Convection-Enhanced
Completed
- Diffuse Intrinsic Pontine Glioma
- Panobinostat Nanoparticle Formulation MTX110
- Convection-Enhanced Delivery (CED)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 2, 2022
Parkinson's Disease Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Convection enhanced
Completed
- Parkinson's Disease
- Convection enhanced delivery/AAV2-GDNF
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Corneal Endothelial Dystrophy Trial in Atlanta, Washington (TTHX1114)
Enrolling by invitation
- Corneal Endothelial Dystrophy
-
Atlanta, Georgia
- +1 more
Jan 21, 2022
Celiac Disease Trial in Saint Paul, Columbus (Cohort 1 in Part A, Cohort 2 in Part A, Cohort 3 in Part A)
Recruiting
- Celiac Disease
- Cohort 1 in Part A
- +6 more
-
Saint Paul, Minnesota
- +1 more
Jan 19, 2023
Colitis, Ulcerative, Biologics, Tofacitiniib Trial in Minden
Terminated
- Colitis, Ulcerative
- +6 more
-
Minden, Niedersachsen, GermanyGastroenterologische Gemeinschaftspraxis Minden
Sep 30, 2021
Virtual Celiac Symptoms Study in Adults and Teenagers
Not yet recruiting
- Celiac Disease
- No Intervention
-
Lexington, MassachusettsTakeda
Jul 15, 2022
Gliomas Trial in New York (Topotecan, Gadolinium, Synchromed II infusion pumps)
Completed
- Gliomas
- Topotecan
- +2 more
-
New York, New YorkColumbia University Irving Medical Center
Jun 30, 2022
Celiac Disease, Coeliac Disease Trial (KAN-101, Placebo)
Not yet recruiting
- Celiac Disease
- Coeliac Disease
- KAN-101
- Placebo
- (no location specified)
Aug 14, 2023
Recurrent High Grade Glioma Trial (MVR-C5252)
Not yet recruiting
- Recurrent High Grade Glioma
- MVR-C5252
- (no location specified)
Nov 6, 2023
Celiac Disease Trial in Boston (Gluten Powder)
Recruiting
- Celiac Disease
- Gluten Powder
-
Boston, MassachusettsCeliac Research Centre Mass General Hospital
Jul 1, 2022
Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)
Active, not recruiting
- Glioma, Malignant
- +4 more
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2022